32.37
Schlusskurs vom Vortag:
$31.04
Offen:
$31.03
24-Stunden-Volumen:
19,729
Relative Volume:
0.43
Marktkapitalisierung:
$1.59B
Einnahmen:
$32.72M
Nettoeinkommen (Verlust:
$-27.55M
KGV:
-56.61
EPS:
-0.5718
Netto-Cashflow:
$-41.40M
1W Leistung:
+5.34%
1M Leistung:
-5.22%
6M Leistung:
+41.41%
1J Leistung:
+886.65%
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NBTX
Nanobiotix Adr
|
32.87 | 1.50B | 32.72M | -27.55M | -41.40M | -0.5718 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.56 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.84 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.14 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.59 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
INSM
Insmed Inc
|
163.86 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-06 | Eingeleitet | TD Cowen | Buy |
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - ChartMill
Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
Nanobiotix (NASDAQ:NBTX) Shares Gap UpShould You Buy? - MarketBeat
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Shares Gap DownWhat's Next? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up Following Analyst Upgrade - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat
Nanobiotix (NASDAQ:NBTX) Stock Price Up 5.8% – Here’s What Happened - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5.8%Should You Buy? - MarketBeat
Looking Into Nanobiotix SA's Recent Short Interest - Sahm
Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.2%Here's What Happened - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap Up – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Trading Up 3.3% – Time to Buy? - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 3.3%Time to Buy? - MarketBeat
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Nanobiotix (NASDAQ:NBTX) Shares Up 5%What's Next? - MarketBeat
Preferred dividends of Nanobiotix SA Sponsored ADR – LS:A2QKZM - TradingView
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives $11.00 Consensus Price Target from Analysts - Defense World
Leerink Partnrs Decreases Earnings Estimates for Nanobiotix - Defense World
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer - MSN
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M - MSN
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):